ValerieIBrownMDPhD

Pediatric Hematology & Oncology • Hershey, PA

Pediatric Hematologic Oncology

Associate Professor of Pediatrics and Director of Experimental Therapeutics for the Division of Pediatric Hematology/Oncology

Join to view full profile

Dr. Brown is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brown's full profile

Already have an account?

Office
500 University Dr
Hershey, PA 17033
Phone+1 800-243-1455

Fax+1 717-531-4789

Education & Training

Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1999 - 2002
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1996 - 1999
Perelman School of Medicine at the University of PennsylvaniaClass of 1996
Perelman School of Medicine at the University of Pennsylvania (formerly known as the University of Pennsylvania School of Medicine)PhD, 1987 - 1992

Certifications & Licensure

PA State Medical License 1997 - 2024
TN State Medical License 2011 - 2014
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Molecular-Guided Therapy for Childhood Cancer Start of enrollment: 2014 Jul 08
Completed
Not Applicable
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy Start of enrollment: 2015 Sep 01
Recruiting
Phase 2
Trial of Tolcapone With Oxaliplatin for Neuroblastoma Start of enrollment: 2015 Dec 01
Terminated
Phase 1
Neuroblastoma Maintenance Therapy Trial Start of enrollment: 2016 Feb 01
Recruiting
Phase 2
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations Start of enrollment: 2020 Mar 12
Recruiting
Phase 1, Phase 2
Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children Start of enrollment: 2016 Feb 16
Completed
Phase 1
Roles: Contact, Principal Investigator
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy Start of enrollment: 2023 Feb 23
Recruiting
Phase 1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytoma.
Shashwat Tripathi, Hinda Najem, Corey Dussold, Sebastian Pacheco, Ruochen Du
The Journal of Clinical Investigation. 2024-08-13
1 citations
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation.
Emma Zulch, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej
Leukemia Research. 2024-08-01
4 citations
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
Giselle L Saulnier Sholler, Genevieve Bergendahl, Elizabeth C Lewis, Jacqueline Kraveka, William Ferguson
Genome Medicine. 2024-02-12

Grant Support

Role Of Mtor Inhibitors And IL7 In Lymphoid MalignanciesNational Cancer Institute2004–2008

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member
American Association for Cancer Research - AACR
Member